All posts by: Michael Zand

About Michael Zand

Geron (GERN) Completes Embryonic Stem Cell Asset Divestiture – StreetInsider.com (subscription)

Geron (GERN) Completes Embryonic Stem Cell Asset DivestitureStreetInsider.com (subscription)On October 1, 2013, Geron Corporation (Nasdaq: GERN) announced the closing of the transaction to divest the Company’s human embryonic stem cell assets pursuant to the terms of the previously disclosed Asset Contribution Agreement, dated as of … …read more   &nbs… Continue reading

2013-10-01 NEWS

Geron unloads its stem cell coffers to BioTime in stock deal – FierceBiotech

Geron unloads its stem cell coffers to BioTime in stock dealFierceBiotechAfter more than a year of not-so-secret negotiations, Geron ($GERN) has finally auctioned off its long-stalled embryonic stem cell pipeline, handing it over to a newfangled BioTime ($BTX) subsidiary in exchange for shares. Under the deal, BioTime gets …Geron Completes Divestiture of Stem Cell AssetsMarketWatchBIOTIME, … Continue reading

2013-10-01 NEWS

Global Stem Cells Group, Inc. Announces Worldwide Alliance with EmCyte Corp … – PR Web (press release)

Global Stem Cells Group, Inc. Announces Worldwide Alliance with EmCyte Corp …PR Web (press release)The Global Stem Cells Group has announced a worldwide alliance with EmCyte Corp. of Fort Myers, Florida to promote in-office regenerative medicine solutions for physicians and practitioners. Share on Twitter Share on Facebook Share on Google+ Share …Live from the Stem … Continue reading

2013-10-01 NEWS